ALBT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Avalon Globocare Corp (ALBT) is not a good buy for a beginner investor with a long-term strategy at this time. The company's financial performance is weak, with significant declines in net income and EPS. Technical indicators suggest a bearish trend, and no strong trading signals are present. Additionally, there are no significant positive catalysts or trading trends to support a buy decision.
The stock shows bearish moving averages (SMA_200 > SMA_20 > SMA_5), with a negative MACD histogram (-0.00131) and an RSI of 49.759 in the neutral zone. Key support and resistance levels indicate limited upward momentum, with a pivot at 0.562 and resistance at 0.668. The stock has a 60% chance of declining in the short term (-1.28% next day, -1.63% next week, -5.31% next month).
The company announced a partnership with Caylent to develop an AI-driven video production platform, which could enhance efficiency and market reach in the future.
Weak financial performance, with significant declines in net income (-84.86% YoY) and EPS (-96.70% YoY). The stock also lacks strong trading trends or insider activity to support a bullish outlook.
In Q3 2025, revenue increased slightly by 1.43% YoY to $350,099. However, net income dropped significantly by -84.86% YoY to -$254,268, and EPS fell by -96.70% YoY to -$0.06. Gross margin improved by 14.51% YoY to 33.06%. Overall, the financials indicate weak profitability and growth.
No analyst rating or price target changes are available for this stock.
